Autres langues GeneOne Life Science, Inc.

Actions

A011000

KR7011000007

Cours en clôture Korea S.E. Autres places de cotation 00:00:00 02/07/2024			Varia. 5j.	Varia. 1 janv.
2 120 ^KRW	+0,95 %		+0,95 %	-25,35 %

16/05	GeneOne Life Science, Inc. annonce ses résultats pour le premier trimestre clos le 31 mars 2024	CI
27/03	GeneOne Life Science, Inc. annonce ses résultats pour l'exercice clos le 31 décembre 2023	CI

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

GeneOne Life Science, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	16/05
GeneOne Life Science, Inc. announced that it has received KRW 3.6000014 billion in funding	28/03
GeneOne Life Science, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	27/03
GeneOne Life Science, Inc. announced that it expects to receive KRW 3.6000014 billion in funding	21/03
GeneOne Life Science, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	14/11
GeneOne Life Science, Inc. announced that it has received KRW 2.46998556 billion in funding	15/09/23
Gene One Life Science to Raise 2.5 Billion Won via Stock Sale	07/09/23
GeneOne Life Science, Inc. announced that it expects to receive KRW 2.46998556 billion in funding	06/09/23
GeneOne Life Science, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	14/08/23
Gene One Life Science to Raise 80 Billion Won via Share Sale	17/05/23
GeneOne Life Science, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	15/05/23
GeneOne Life Science, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	14/11/22
Varicella Zoster Infections Pipeline Landscape Analysis of 03+ Companies by DelveInsight \| Leading Companies - Curevo Vaccine, GeneOne Life Science, SK Bioscience, and Others	04/10/22
GeneOne Life Science, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	16/08/22
GeneOne Life Science, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022	16/05/22
GeneOne Life Science, Inc. announced that it has received KRW 11.7 billion in funding	15/04/22
GeneOne Life Science, Inc. announced that it expects to receive KRW 11.7 billion in funding	13/04/22
GeneOne Life Science, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021	08/11/21
SK bioscience : S.Korea to begin producing Novavax COVID-19 vaccine as early as June	12/04/21
GeneOne Life Science : VGXI and Geneos Therapeutics Expand Partnership for Personalized Cancer Immunotherapies	17/03/21

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues GeneOne Life Science, Inc.

Actions

A011000

KR7011000007

Autres langues

Filtres